Clinical Studies (1)
- Kuzubov : Study aims to assess the immunogenicity, reactogenicity and safety of the VAC?6 vaccine in healthy volunteers aged 18-60 years
Other information
If you would like to contact the site, please email: ccb@ateneo.univr.it
The data is updated up to